Literature DB >> 33415452

Does sublingual microscopy correlate with nailfold videocapillaroscopy in systemic sclerosis?

Mislav Radic1,2, Julie Thomas1, Sean McMillan1, Tracy Frech3,4.   

Abstract

In this study, we examine sublingual videomicroscopy and nailfold videocapillaroscopy (NVC) features in systemic sclerosis (SSc) patients presenting for routine care. Consented participants met classification criteria for SSc. Sublingual videomicroscopy testing was performed in each subject, followed by a NVC assessment. Sublingual assessment provided a density measurement, red blood cell fraction (RBC fract), and perfused boundary region (PBR) score. NVC evaluator defined nailfold findings as normal; specific changes for "early," "active," and "late" scleroderma pattern; or "non-specific" changes. Microangiopathy evolution score was calculated for each participant. Statistical evaluation was performed by non-parametric tests to assess the correlation of the two tools. Thirty-nine SSc patients with limited cutaneous disease participated in this study. Most participants had late pattern NVC. There was a highly significant association between the total sublingual microvascular density and number of capillaries measured by NVC (r = 0.569, P = 0.0002), and statistically significant negative correlation between sublingual total microvascular density and microangiopathy evolution score (r = 0.532, P = 0.0006). There was significant, negative correlation between the total sublingual microvascular density and disorganization of vascular array and capillary ramification (r = 0.461, P = 0.003) and degree of giant capillaries (r = 0.387, P = 0.01). There was no correlation between RBC fract and PBR with NVC parameters. This study showed a significant correlation between sublingual videomicroscopy and NVC in terms of sublingual total microvascular density and microangiopathy evolution score. These preliminary results further support the serial use of a non-invasive and automated sublingual microvascular function testing and glycocalyx measurement in the clinical setting. KEY POINTS: • Tools that longitudinally assess microvascular function and morphologic features are important for monitoring SSc vasculopathy. • Nailfold and sublingual microscopy can identify a loss of capillary density in SSc patients.

Entities:  

Keywords:  Nailfold videocapillaroscopy; Sublingual videocapillaroscopy; Systemic sclerosis; Vasculopathy

Mesh:

Year:  2021        PMID: 33415452      PMCID: PMC8127337          DOI: 10.1007/s10067-020-05495-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  4 in total

1.  Assessment of capillary density in systemic sclerosis with three different capillaroscopic methods.

Authors:  Marie Wildt; Dirk M Wuttge; Roger Hesselstrand; Agneta Scheja
Journal:  Clin Exp Rheumatol       Date:  2012-05-29       Impact factor: 4.473

2.  Results from an American pilot survey among Scleroderma Clinical Trials Consortium members on capillaroscopy use and how to best implement nailfold capillaroscopy training.

Authors:  Marcus H Snow; Lesley-Ann Saketkoo; Tracy M Frech; Jacob R Stever; Nicholas Lebedoff; Ariane L Herrick; Maurizio Cutolo; Vanessa Smith
Journal:  Clin Exp Rheumatol       Date:  2019-04-05       Impact factor: 4.473

3.  Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis.

Authors:  M Cutolo; A Sulli; C Pizzorni; S Accardo
Journal:  J Rheumatol       Date:  2000-01       Impact factor: 4.666

4.  Decreased nailfold capillary density in limited scleroderma with pulmonary hypertension.

Authors:  Y Y Ong; T Nikoloutsopoulos; C P Bond; M D Smith; M J Ahern; P J Roberts-Thomson
Journal:  Asian Pac J Allergy Immunol       Date:  1998 Jun-Sep       Impact factor: 2.310

  4 in total
  1 in total

Review 1.  Animal Models of Systemic Sclerosis: Using Nailfold Capillaroscopy as a Potential Tool to Evaluate Microcirculation and Microangiopathy: A Narrative Review.

Authors:  Angélica Mandujano; Melissa Golubov
Journal:  Life (Basel)       Date:  2022-05-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.